United Kingdom, March 01, 2018: The European Medical Journal leaps into March with the year’s first edition of our flagship publication, EMJ 3.1. This edition is packed with an assortment of peer-reviewed articles from a body of therapeutic areas, including reproductive health, dermatology, and cardiology, to name a few. Containing papers from across the medical sphere, EMJ 3.1 aims to inform and educate readers on an interdisciplinary level, with articles written by a number of experts, all of whom are influencers and visionaries in their specific fields.
Neidhart, one of the EMJ Rheumatology Editorial Board members, has penned an intriguing feature article that considers the past and present clinical practice guidelines for rheumatoid arthritis, as well as recommendations and actions suggested by the European League Against Rheumatism (EULAR) for early cases.
Reproductive biologists can indulge in this year’s Editors Pick, penned by Jain, which brings to light the current role of intrauterine insemination in infertility management. The article provides an insight into one of the oldest infertility treatment options available and questions whether there is still a place for this method in the assisted-reproductive world, considering the huge surge of in vitro fertilisation use as the current first-line treatment option.
Professionals in dermatology can appreciate a number of articles, including a case report from Starace et al. describing the appearance of longitudinal melanonychia in a 17-year-old female. Kelly and Ryan, in their review, discuss the newly emerging problems associated with psoriasis that go “beyond the skin”, the evidence surrounding its links to sleep apnoea and liver disease, and the association of psoriasis with anxiety and depression. Additionally, they detail the increasing realisation of how we need to expand our knowledge in order to provide the appropriate care and management to improve patient health outcomes. Available online now: http://www.emjreviews.com/european-medical-journal/journal/european-medical-journal-3-1-2018/
The staff at the European Medical Journal are positive that EMJ 3.1 will inspire the medical community and spawn topics of conversation for the months to follow. Spencer Gore, CEO of the European Medical Group, expressed his enthusiasm for the publication: “We enter spring in the best way possible by providing a number of articles from pioneering scientists addressing pertinent areas in the field. The passion they have for their particular areas of research shine through in this eJournal, and we hope that this is evident to our readers as they discover the contents enclosed.” For even more up-to-the-minute content on all therapeutic areas, connect with EMJ on Facebook, Twitter, LinkedIn, and Google+.
About the European Medical Journal
The European Medical Journal is an independent company that annually produces a collection of open-access medical eJournals covering therapeutic areas such as Respiratory, Gastroenterology, Cardiology, and Urology. By combining editorials from key opinion leaders with concise news coverage from the leading congresses within the medical industry, we aim to deliver first-class insight into ground-breaking changes and advances in medicine. The production of our high-quality, peer-reviewed eJournals, and our collaborations with independent clinical bodies result in a dynamic and contemporary tool with which to assist industry professionals across Europe in progressively developing their performance and efficacy.
Name: Stacey Rivers
Number: 01245 334452
E-mail: [email protected]